arrow
R

Robert G. Bristow

University of Manchester
H指数:98
被引数:4.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer

前列腺癌中基因组驱动突变的分子异质性与临床影响

2026-10-160
OAAI
2026-09-300
OAAI
Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer

前列腺癌中双等位基因表观遗传失活的复发机制揭示了新的潜在肿瘤抑制基因

2026-09-090
OAAI
Integrated signatures define mutational processes in prostate cancer

整合特征定义前列腺癌中的突变过程

Nature
IF48.5
2026-09-090
OAAI
Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancer

克隆演化和转录可塑性塑造了前列腺癌的转移播散途径

2025-12-230
OAAI
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry

致病性变异揭示非洲血统男性前列腺癌遗传检测的候选基因

2025-10-020
OAAI
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy

缺氧相关基因特征在接受雄激素剥夺治疗和放射治疗的高危局限性前列腺癌中不是预后的

2025-03-010
OAAI
Genomic evolution shapes prostate cancer disease type

基因组进化塑造前列腺癌疾病类型

2024-03-010
OAAI
First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer
2023-06-0123
OAAI
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

晚期前列腺癌-转移性和/或去势抵抗性前列腺癌患者的管理: 晚期前列腺癌共识会议 (APCCC) 2022的报告

2023-05-0166
OA
Germline structural variants shape prostate cancer clinical and molecular evolution
2023-04-041
PRE